Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs.
Piyush BaindaraSonali AgrawalOctávio Luiz FrancoPublished in: Expert review of anti-infective therapy (2022)
, during the development of disease in humans, suggests that they are potential host targets for which to develop host-directed therapies. By taking advantage of these common infection strategies, there is a chance that a number of available drugs can be repurposed to fight both malaria and tuberculosis, and their co-infections.